{"pmid":32278367,"title":"COVID-19: Respiratory support outside the intensive care unit.","text":["COVID-19: Respiratory support outside the intensive care unit.","Lancet Respir Med","McEnery, Tom","Gough, Ciara","Costello, Richard W","32278367"],"journal":"Lancet Respir Med","authors":["McEnery, Tom","Gough, Ciara","Costello, Richard W"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32278367","week":"202016|Apr 13 - Apr 19","doi":"10.1016/S2213-2600(20)30176-4","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663890921974923264,"score":7.9164424,"similar":[{"pmid":32035509,"title":"Coronavirus epidemic: preparing for extracorporeal organ support in intensive care.","text":["Coronavirus epidemic: preparing for extracorporeal organ support in intensive care.","Lancet Respir Med","Ronco, Claudio","Navalesi, Paolo","Vincent, Jean Louis","32035509"],"journal":"Lancet Respir Med","authors":["Ronco, Claudio","Navalesi, Paolo","Vincent, Jean Louis"],"date":"2020-02-10T11:00:00Z","year":2020,"_id":"32035509","week":"20207|Feb 10 - Feb 16","doi":"10.1016/S2213-2600(20)30060-6","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352134713737217,"score":60.884087},{"pmid":32255489,"title":"Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.","text":["Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.","Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.","Clin Infect Dis","Perinel, Sophie","Launay, Manon","Botelho-Nevers, Elisabeth","Diconne, Eric","Louf-Durier, Aurore","Lachand, Raphael","Murgier, Martin","Page, Dominique","Vermesch, Regine","Thierry, Guillaume","Delavenne, Xavier","32255489"],"abstract":["Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen."],"journal":"Clin Infect Dis","authors":["Perinel, Sophie","Launay, Manon","Botelho-Nevers, Elisabeth","Diconne, Eric","Louf-Durier, Aurore","Lachand, Raphael","Murgier, Martin","Page, Dominique","Vermesch, Regine","Thierry, Guillaume","Delavenne, Xavier"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255489","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cid/ciaa394","source":"PubMed","locations":["optimal"],"topics":["Treatment"],"weight":1,"e_drugs":["Hydroxychloroquine"],"_version_":1663450393504382977,"score":60.268967},{"pmid":32238613,"title":"Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.","text":["Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.","The 2019-novel coronavirus predominantly affects the respiratory system with manifestations ranging from upper respiratory symptoms to full blown acute respiratory distress syndrome (ARDS). It is important to recognize the risk factors, categorize severity and provide early treatment. Use of high flow devices and non-invasive ventilation has been discouraged due to high chances of aerosol generation. Early intubation and mechanical ventilation are essential to prevent complications and worsening, especially in resource-limited settings with very few centers having expertise to manage critical cases. Hydrophobic viral filter in the ventilator circuit minimizes chances of transmission of virus. Strategies to manage ARDS in COVID-19 include low tidal volume ventilation with liberal sedation-analgesia. At the same time, prevention of transmission of the virus to healthcare workers is extremely important in the intensive care setting dealing with severe cases and requiring procedures generating aerosol. We, herein, provide guidance on non-invasive respiratory support, intubation and management of ARDS in a child with COVID-19.","Indian Pediatr","Sundaram, Manu","Ravikumar, Namita","Bansal, Arun","Nallasamy, Karthi","Basavaraja, G V","Lodha, Rakesh","Gupta, Dhiren","Odena, Marti Pons","Ashwath, R N Ram","Jayashree, Muralidharan","32238613"],"abstract":["The 2019-novel coronavirus predominantly affects the respiratory system with manifestations ranging from upper respiratory symptoms to full blown acute respiratory distress syndrome (ARDS). It is important to recognize the risk factors, categorize severity and provide early treatment. Use of high flow devices and non-invasive ventilation has been discouraged due to high chances of aerosol generation. Early intubation and mechanical ventilation are essential to prevent complications and worsening, especially in resource-limited settings with very few centers having expertise to manage critical cases. Hydrophobic viral filter in the ventilator circuit minimizes chances of transmission of virus. Strategies to manage ARDS in COVID-19 include low tidal volume ventilation with liberal sedation-analgesia. At the same time, prevention of transmission of the virus to healthcare workers is extremely important in the intensive care setting dealing with severe cases and requiring procedures generating aerosol. We, herein, provide guidance on non-invasive respiratory support, intubation and management of ARDS in a child with COVID-19."],"journal":"Indian Pediatr","authors":["Sundaram, Manu","Ravikumar, Namita","Bansal, Arun","Nallasamy, Karthi","Basavaraja, G V","Lodha, Rakesh","Gupta, Dhiren","Odena, Marti Pons","Ashwath, R N Ram","Jayashree, Muralidharan"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238613","week":"202014|Mar 30 - Apr 05","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135523237888,"score":59.585686},{"pmid":32267979,"title":"COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.","text":["COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.","As the number of cases of COVID-19 (SARS-CoV-2) rise in the United States (US), the number of severe cases (those requiring ICU admission) rise with it. Initially, the estimate for severe cases was approximated at 5% based on experience from China.(1, 2) However, the World Health Organization's (WHO) estimate from China for severe and critical cases is near 20% (Table).(3) The primary clinical feature of COVID-19 is pneumonia, the severity of which directs the clinical course; it has been estimated that, of patients admitted to the ICU, up to half may require either invasive or non-invasive ventilatory support.(4) This has created an unprecedented situation for emergency and critical care medicine.","Pharmacotherapy","Stringer, Kathleen A","Puskarich, Michael A","Kenes, Michael T","Dickson, Robert P","32267979"],"abstract":["As the number of cases of COVID-19 (SARS-CoV-2) rise in the United States (US), the number of severe cases (those requiring ICU admission) rise with it. Initially, the estimate for severe cases was approximated at 5% based on experience from China.(1, 2) However, the World Health Organization's (WHO) estimate from China for severe and critical cases is near 20% (Table).(3) The primary clinical feature of COVID-19 is pneumonia, the severity of which directs the clinical course; it has been estimated that, of patients admitted to the ICU, up to half may require either invasive or non-invasive ventilatory support.(4) This has created an unprecedented situation for emergency and critical care medicine."],"journal":"Pharmacotherapy","authors":["Stringer, Kathleen A","Puskarich, Michael A","Kenes, Michael T","Dickson, Robert P"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267979","week":"202015|Apr 06 - Apr 12","doi":"10.1002/phar.2394","keywords":["COVID-19","Corona virus","Intensive Care Unit","acute respiratory distress syndrome (ARDS)"],"source":"PubMed","locations":["US","United States","China"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1663609715744047104,"score":57.93818},{"pmid":32208493,"title":"Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs).","text":["Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs).","Swiss Med Wkly","Swiss Society Of Intensive Care Medicine","32208493"],"journal":"Swiss Med Wkly","authors":["Swiss Society Of Intensive Care Medicine"],"date":"2020-03-26T11:00:00Z","year":2020,"_id":"32208493","week":"202013|Mar 23 - Mar 29","doi":"10.4414/smw.2020.20227","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352133746950144,"score":57.35979}]}